Skip to main content

Advertisement

Table 1 Patient characteristics

From: Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis

  Baseline Week 4 Week 8 Week 12 Week 16 Week 20 Week 24
Hemoglobin 12 11.7 11.3 10.5 10.9 11.4 11.6
Platelet count 188 246 277 297 314 296 250
WBC 6.3 6.8 6.9 7.3 7.4 8.0 8.3
Creatinine 0.85 0.88 0.89 0.92 1.02 1.16 1.03
ALT/AST Normal Normal Normal Normal Normal Normal Normal
Amylase/Lipase Normal Normal Normal Normal Normal Normal Normal
EKG Normal Normal Normal Normal Normal Normal Normal
Weight (Kg) 77.9 78.4 80.5 83.7 85.2 85.6 84.6
Tryptase 10.2 NA 10.8 9.6 NA 9.5 9.1
Ruxolitinib dose 5 mg BID 10 mg BID 20 mg BID 15 mg BID 10 mg BID 10 mg BID 5 mg BID